In an interview, synthetic biologist Peter Carr explains research on synthetic cells, their potential benefits and hazards, ...

Vertex claimed the two drugs in the deal could eventually bring in more than $5 billion annually. Still, the high price it ...

Insilico Medicine ("Insilico," HKEX: 3696), a clinical-stage biotechnology company powered by generative AI, today announced the initiation of the Phase III clinical trial for Rentosertib, its ...

Clinical Program Advances Following Favorable Safety Review; Peer-Reviewed Publication Further Validates Deciparticle™ Platform ...

King Faisal Specialist Hospital & Research Centre (KFSHRC) has signed five key international agreements during the Saudi-US ...

Malaysia-based biotechnology and wellness company Alps Global Inc. is set to expand to the Philippines through partnerships with local healthcare and industry experts, with plans to establish an ...

In a world where billions of people are connected through social media, are we truly becoming more connected, or are we the ...

FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures ...

Veteran biosensor innovator and technology leader brings decades of experience developing and scaling breakthrough ...

Company expects existing supply will suffice to complete clinical trial and lead to cost savings HOUSTON, July 7, 2026 /PRNewswire/ -- FibroBiologics, Inc. (Nasdaq: ...

Industrial SalesLeads’ June 2026 report on planned capital project spending shows continued momentum in the Industrial ...

Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging ...